Azenosertib median duration of response (mDOR) updated to 6.3 months in the ongoing DENALI Part 1b clinical trial in patients with platinum-resistant ovarian cancer (PROC) and continues to demonstrate ...
Q4 2024 Earnings Call Transcript March 13, 2025 Allogene Therapeutics, Inc. beats earnings expectations. Reported EPS is ...
His openness about living with bipolar disorder highlights the little-discussed fact that people with this condition face one of the highest suicide risks of any mental illness. Bipolar disorder ...
Drinking alcohol might appear to help you fall asleep initially, but it diminishes your quality rest. These nighttime tips ...
The Punch on MSN1h
Medicine not for clever people – Tokunbo Shitta-BeyThe Chief Executive Officer of Duchess International Hospital, Lagos, Tokunbo Shitta-Bey tells Faith Ajayi about his journey ...
LEO Pharma A/S, a global leader in medical dermatology, today presented late-breaking data showcasing responses in a subgroup of patients from the DELTA 1 and 2 trials at the 83 rd American Academy of ...
Mamamia on MSN22h
The best (and worst) time to exercise during your cycle.If you're anything like us, exercising is the absolute last thing you want to do when you're on your period. Sit on the sofa ...
Full Year 2024 Results Key Financial Results Net loss: US$257.6m (loss ...
With proven ingredients like biotin, caffeine and niacinamide, this color-safe pair aims to promote stronger, thicker locks.
The clinical trial results of India’s first CAR T-cell therapy, published in The Lancet, show that it worked for nearly 73 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback